Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

Techne

(

TECH

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Techne as such a stock due to the following factors:

  • TECH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.5 million.
  • TECH has traded 900 shares today.
  • TECH is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in TECH with the Ticky from Trade-Ideas. See the FREE profile for TECH NOW at Trade-Ideas

More details on TECH:

Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The stock currently has a dividend yield of 1.4%. TECH has a PE ratio of 30.2.

The average volume for Techne has been 194,600 shares per day over the past 30 days. Techne has a market cap of $3.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.51 and a short float of 5.2% with 9.09 days to cover. Shares are down 4.2% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null